The combination of metformin and berberine synergistically inhibited DNMT1 expression by reducing transcription factor SP1 and 3‐phosphoinositide‐dependent protein kinase‐1 (PDPK1) expression in NSCLC cells [13]. This evidence concerns the gene DNMT1 and non-small cell lung carcinoma.